The PM Society's activities align with the challenges and opportunities facing today's marketers in an increasingly complex healthcare arena. You can read more about the key topics we cover here.
Projects rarely run like clockwork, and sometimes don’t deliver what they promised. In Pharmaceutical Marketing far too many fail to deliver good quality in reasonable timeframes. Sanofi's Calum Shaw explains why.
The Accelerated Access Review (AAR), an independently chaired report supported by the Wellcome Trust, has published its Final Report.
Digital Works III took place before the PM Society Digital Awards 2015 featuring a collection of amazing speakers from WebMD, BMS, Search Unlimited, GSK, Boehringer Ingelheim, Veeva, NHS Choices, & M3. Videos of all the presentations are online now.
Ben Mansfield, Committee Member & Deputy MD of Four MSA, explains how to engage with HCPs through Native Advertising.
The PM Society Market Access Interest Group Meeting met on the 7 September at the ABPI offices in Victoria, London, led by Craig Bradley from Shire. The meeting focused on a survey planned to create awareness of the MA interest group and feed into a short-term educational output, such as a “market access 101” and longer-term event plans.
NHS England is planning to rationalise the approach to medicines evaluation via the development of four regional medicines optimisation committees.
Your opportunity to be part of this initiative. Please share your knowledge and examples of best practice in patient engagement.
The PM Society Market Access Interest Group met by telecon on 19 May 2016, led by Craig Bradley from Shire. Attendees included Simon Fogg from AbbVie, Gavin Coetzee and Hassan Chaudhury from Health iQ, Kevin Blakemore from Bright Blue Box Consultancy, Trishal Boodhna from emotive and Clare Foy from IMS Health.
The third Digital Works Meeting brought together nine experts from industry and the NHS who had something to say about “how digital works”. Read what they had to say in our full report.
Integrated marketing became a buzz word in the early 1970s. 40 years on, babies born today are ‘data natives’, expecting a world that is ‘smart’ and which effortlessly responds to their needs, preferences and habits. So how is pharma keeping up with the digital revolution?
As pharma evolves at a revolutionary speed, what do today’s young executives need to stay ahead of the crowd and what can they learn from some of the brightest and best who are already doing just that?
As pharma evolves at a revolutionary speed, what do today’s young executives need to stay ahead of the crowd and what can they learn from some of the brightest and best who are already doing just that? Thomas Butler, Sanofi
A full report, including speaker slides, from the Market Access debate "Industry and the NHS – can promotion and partnership co-exist?" on Friday 31 January 2014.
The PM Society has added an educational pre-event to the PM Society Advertising Awards on Friday, 31 January 2014 as it confirms finalists for 2013.
What is Closed Loop Marketing and how can it be used in pharmaceutical and healthcare marketing?
What steps can you take to get your company started with Closed Loop Marketing?
If your New Year's resolution was to develop your skills in digital marketing, we're here to give you a head start with this free extract of Digital Unlocked.
For the UK pharmaceutical industry, biotech or devices firms, any discussion around market access tends to be synonymous with ‘hurdles’ or ‘barriers’ to a new product being introduced to the ever-changing National Health Service. But opening up the conversation to find a definition of market access leads to a far more interesting debate.
Personal career development is simply a matter of choosing the right mindset and being smart enough to take some steps in the right direction. Here are 10 steps you can take to get started today.
This month Heather Simmonds of the PMCPA, returns to talk about the ABPI Code of Practice for the Pharmaceutical Industry and its impact on your working life. At 9.30am on Thursday 31 October 2013 Heather will be discussing some of the upcoming changes to the Code.
What are the drivers and barriers for developing talent in pharmaceutical marketing and associated disciplines?
The latest research on patient behaviour relating to medicines and opportunities for pharma to help in improving adherence were discussed at the ABPI Patient Adherence meeting.
Ben Tilly, Digital Customer Marketing Manager of GSK and Dave Pinnington, Digital Marketing Director EUCAN of Pfizer discuss topics including Digital strategy, Social media and industry regulation, Interacting with patients online and how pharma's digital use compares to other industries.
Shona Davis of MSD discusses the digital strategy behind Univadis, user engagement, product design, and how content strategy can help avoid regulatory problems.
What's the role of medicines management in the new NHS?
Alex Bulter, Andrew Spong and Faisal Ahmed, founders of the podcast Digitally Sick, debate digital in pharma.
Heather Simmonds, Director of the Prescription Medicines Code of Practice Authority (PMCPA), discusses the challenges and issues surrounding the Code and its application.
Dr Neil Fraser, head of long-term conditions at NHS Rushcliffe CCG and a GP in East Leake, Nottinghamshire and Kevin Blakemore, NHS Partnership Manager at ABPI join Paul Midgley to discuss joint working from both an NHS and pharma perspective and to ask how the NHS and Industry can best work together.
What makes for winning work? Some of the winners of the PM Society Digital Media Awards 2012 discuss their winning campaigns, and Awards judges reveal the rationale behind their decisions.
In the first PM Society Digital Breakfast, Boehringer Ingelheim's John Pugh discussed Syrum, the first Facebook game from Boehringer Ingelheim. Andy Stafford from Nitro Digital also joined the discussion.
Top tips from Pharma's digital experts
The final Joint Working – Why Should We Bother? Regional meeting was a chance for delegates to step back and think about how Industry and NHS work together.
Delegates at the first ABPI Regional Interest Group London meeting on 13 June heard from a panel of NHS and industry speakers and took part in interactive sessions that honed their understanding of Joint Working.
The second of the ABPI's regional events has been held in the Midlands and East region. The Midlands and East RIG has been established as the focus for partnership working in Midlands and East and is building trust in, and understanding of, Joint Working.
The first ever ABPI Regional Event (South) took place last Friday, 10 May in Reading and saw an audience of pharma with a smattering of NHS learn more about the ABPI regional groups and joint-working.
Introducing trust, reputation and social media in healthcare
What does pharma need to know in order to ensure a successful partnership at local level? Join the ABPI NHS Partnership Team managers, together with local stakeholders including senior members of AHSNs and CCGs, to enhance your understanding of the new local NHS with a specific focus on joint working.
If you’re considering developing an app for your brand or client, how can you ensure it generates a positive return on your investment? Here are a few tips and questions for you to consider when it comes to developing your own mobile app strategy.
The PM Society, the organisation driving marketing excellence and education in the life sciences industries, has appointed David Southern, director, Pathway Communications to lead its NHS Partnerships Interest Group.
Speaking at the live PM Society Digital Breakfast online, which attracted a record-breaking audience of 303, Heather Simmonds, Director of the PMCPA asked industry for its detailed input on frustrations about the Code of Practice, particularly as it relates to digital.
What is joint working with the NHS, how can pharma get involved, and how can you ensure you partnership is successful?
Everything you need to know about digital pharma is here in this expert starter guide, written by Dr Paul Tunnah and Faisal Ahmed
Read highlights and view speaker slides from the PM Society/Wellards joint forum on the future of market access
The Digital Interest Group is advised by industry experts to help promote and understand digital strategies and marketing across the life sciences sector.
The PM Society Digital Interest Group is launching its monthly Digital Breakfasts, a series of brief interactive webinars keeping you at the forefront of digital in pharmaceutical marketing and healthcare.
The Digital Pioneer Award, now in its third year, recognises the increasing importance of digital and those that pushed the digital boundaries within their pharma environment.
Faisal Ahmed, Head of digital at Life Healthcare, discusses his hopes for 2012 and how the pharma industry can use the visually-driven social network, Pinterest.
New evidence indicates nearly 90% of NHS commissioning influencers with experience of an NHS/ industry joint working or partnership project would consider doing it again to improve patient care.
Over 100 industry and associated executives logged on for the first PM Society Digital Society Breakfast this morning for live interactive chat with John Pugh, Boehringer Ingelheim and Andy Stafford, Nitro Digital, hosted by PM Society Digital Lead Carwyn Jones.
Chaired by leading expert in digital media Alex Butler, the meeting drew on the experience of two eminent keynote speakers, and also showcased three award-winning digital case studies.
The ever-changing health regulations and policies in Europe offer tremendous challenges for pharmaceutical and biotechnology companies when bringing new therapies to patients.
Building meaningful relationships between patients, patient groups and the pharmaceutical industry
Practical advice and insight into opportunities in the changing NHS Landscape at the inaugural meeting of the PM Society NHS Engagement Special Interest Group
The Digital Interest Group is committed to highlighting excellence in all the relevant areas and to helping PM Society members to improve digital competency and share best practice across the industry as interest and uptake increases.
Partnership working between the industry and the NHS is one of the key issues for today's pharma and life sciences marketers
The PM Society Patient Engagement Interest Group has been set up to examine the potential for industry to add real value in ensuring patients are included in decisions, strategies and policies which shape their healthcare.
The PM Society Market Access Interest Group will address the growing need for multiple stakeholders to understand their role in 'market access'.
Incorporating PriMe, the Personal Development Interest Group has been set up to examine how the interlinking training needs of marketers and their peers can be met, including the training needs of personnel in the brand team across R&D, market research, business intelligence, market access, medical affairs and regulatory affairs.
CAN Advertising discuss the creative execution and delivery of a global campaign